Biotech Pre-Seed Investors & VC Firms
896 firms in this list, with a median first check of $270K. 229 of them lead rounds. Generated from verified public data and updated continuously.
AIX Ventures
San FranciscoPre-Seed–Series A$1M – $5M
9 people
BioAdvance
ConshohockenPre-Seed–Late Stage$500K – $1.5M
18 people
GoAhead Ventures
Menlo ParkPre-Seed–Series A$500K – $1M
3 people
FoodLabs
BerlinPre-Seed–Series A
22 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
25 people
Blue Revolution Investments G.P.
BergenPre-Seed–Series A
30 people
Emles Venture Partners
New YorkPre-Seed–Seed
14 people
EMV Capital
LondonPre-Seed–Series B
20 people
NYU Innovation Venture Fund
New YorkPre-Seed–Series A$100K – $500K
32 people
PreSeed Ventures
Kongens LyngbyPre-Seed–Seed
31 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
34 people
TMV Logistics
New YorkPre-Seed–Series A$1.5M
13 people
Illinois Ventures
ChampaignPre-Seed–Late Stage
21 people
Signal Peak Ventures
Salt Lake CityPre-Seed–Series B$250K – $5M
17 people
Ankur Capital
MumbaiPre-Seed–Series A$275K – $15M
22 people
HCVC
ParisPre-Seed–Series A$100K – $1M
6 people
MPM Capital
Pre-Seed–Late Stage
27 people
Faber
LisbonPre-Seed–Series A$2.7M
18 people
Pan-Lin Capital
ShanghaiPre-Seed–Growth
5 people
Sustainable Food Ventures
SeattlePre-Seed–Series A
3 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
17 people
Visionaries Club
BerlinPre-Seed–Late Stage$900K
16 people
Oregon Venture Fund
PortlandPre-Seed–Growth$500K – $5M
9 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
Related lists
Pre-Seed Investors & VC Firms (5679)Biotech Investors & VC Firms (2107)Pre-Seed Investors & VC Firms in United States (2090)AI & Machine Learning Pre-Seed Investors & VC Firms (1855)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)SaaS Pre-Seed Investors & VC Firms (1575)Pre-Seed Investors & VC Firms in Global (1485)Fintech Pre-Seed Investors & VC Firms (1477)Healthtech Pre-Seed Investors & VC Firms (1328)
Data sourced from public filings and firms' own websites — see our methodology.







































































